title: [A case of lymph node recurrence after curative operation of type 4 gastric cancer, successfully treated with TS-1].
abstract: A 74-year-old male underwent left upper abdomen excision (LUAE) and D3 lymph node dissection for type 4 gastric cancer. Nine months after the surgery, abdominal computed tomography (CT) revealed paraportal lymph node recurrence (#8p), 22 mm in size. One hundred mg/body/day of TS-1 was administrated for 14 days, followed by 7 days rest, as one course. A complete response was obtained after the second course. This treatment was stopped after the 11 course because the patient suffered prolonged grade 1 fatigue. The patient has been in good health without a recurrence for 1 year and 5 months after the recurrence. Adverse effects included rash (grade 1), diarrhea (grade 2), fatigue (grade 2) and neutrophils neutropenia (grade 2).
authors: Dept. of Surgery, Sakai Municipal Hospital.
authors: Kazuyoshi
authors: K
authors: Yamamoto
authors: Hiroshi
authors: H
authors: Imamura
authors: Hiroshi
authors: H
authors: Furukawa
authors: Hitoshi
authors: H
authors: Kato
authors: Koji
authors: K
authors: Esumi
authors: Norikazu
authors: N
authors: Masuda
authors: Junzo
authors: J
authors: Shimizu
authors: Hideyuki
authors: H
authors: Ishida
authors: Seizo
authors: S
authors: Masutani
authors: Masayuki
authors: M
authors: Tatsuta
authors: Takatoshi
authors: T
authors: Kawasaki
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000556:secondary* / Q000601:surgery; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004338:Drug Combinations; D005743:Gastrectomy; D006801:Humans; D008197:Lymph Node Excision; D008198:Lymph Nodes / Q000473:pathology*; D008207:Lymphatic Metastasis; D008297:Male; D010094:Oxonic Acid / Q000008:administration & dosage*; D011725:Pyridines / Q000008:administration & dosage*; D012074:Remission Induction; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000473:pathology* / Q000601:surgery; D005641:Tegafur / Q000008:administration & dosage*
chemical_list: D000964:Antimetabolites, Antineoplastic; D004338:Drug Combinations; D011725:Pyridines; C079198:S 1 (combination); D005641:Tegafur; D010094:Oxonic Acid